Integra Lifesciences Holdings Corp (IART)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$12.99

Buy

$13.85

arrow-down$-0.63 (-4.48%)

Prices updated at 12 Dec 2025, 22:56 EST

Prices minimum 15 mins delay

Prices in USD

Integra Lifesciences Holdings Corp is engaged in development, manufacturing, and marketing of product lines from its technology for applications ranging from burn and deep tissue wounds to repair of dura mater in the brain to repair of nerve and tendon.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Stuart M. Essig, PhD

CEO

Ms. Mojdeh Poul

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

4,396

Head office

1100 Campus Road

Princeton

United States

08540

+1 609 275-0500

michael.beaulieu@integralife.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Christian Stanton Schade Independent Director	0.12m
Dr. Jeffrey A. Graves Independent Director	0.05m
Ms. Barbara B. Hill Presiding Independent Director	0.05m
Dr. Keith Bradley,PhD Independent Director	0.08m
Mr. Stuart M. Essig, PhD Executive Chairman of the Board	0.12m
Mr. Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary	-
Mr. Robert T. Davis, Jr Executive Vice President and President, Tissue Technologies	0.54m
Mr. Jeffrey A. Mosebrook Senior Vice President, Finance and Principal Accounting Officer	-
Ms. Mojdeh Poul President, Chief Executive Officer and Director	-
Mr. Michael McBreen Executive Vice President and President, Codman Specialty Surgical	0.64m
Ms. Shaundra D. Clay Independent Director	0.08m
Ms. Renee Wonlai Lo Independent Director	0.08m
Mr. Harvinder Singh Executive Vice President and President, International	0.51m
Ms. Lea Daniels Knight Executive Vice President and Chief Financial Officer	0.62m
Ms. Chantal Veillon-Berteloot Executive Vice President and Chief Human Resources Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	10,229,183
Rubric Capital Management LP	7,653,934
Vanguard Group Inc	7,578,293
BlackRock Fund Advisors	7,330,332
iShares Core S&P Small-Cap ETF	4,004,618

Director dealings

Date chevron-l-regular chevron-r-regular	Action
03 Dec 2024	-
02 Dec 2024	-
01 Sep 2024	-
19 Aug 2024	-
03 Jul 2024	-
01 Jul 2024	-
23 May 2024	-
21 May 2024	-
09 May 2024	-
09 May 2024	-
09 May 2024	-
09 May 2024	-
09 May 2024	-
09 May 2024	-
12 May 2024	-
12 May 2024	-
09 May 2024	-
09 May 2024	-
09 May 2024	-
09 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.